#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma Cryoglobulinaemia Laryngeal squamous cell carcinoma Hepatitis D Thermal burn Wolfram syndrome Philadelphia chromosome positive Hypoparathyroidism Immunodeficiency Microscopic polyangiitis Cushing's syndrome Hormone-dependent prostate cancer Myasthenia gravis Optic glioma Pancreatic carcinoma metastatic More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Basic Information Mantle cell lymphoma refractory – Basic Information Lennox-Gastaut syndrome – Trials in Disease Sarcoma – Diagnostics Hairy cell leukaemia – Treatment Noonan syndrome – Life with Disease Small intestine leiomyosarcoma Leiomyosarcoma – Life with Disease Propionic acidaemia – Life with Disease Antithrombin III deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZINC CHLORIDE Osimertinib Levofloxacin Hemihydrate ADX-324 Tiragolumab REGN7544 Pemafibrate Hepatitis B Surface Antigen HUMAN COAGULATION FACTOR XIII Ly3437943 Sodium Nirogacestat Hydrobromide SGT-003 Lamivudine Mva-209-Fsp-B1 Gad20-209-Fsp-A1 Indapamide Berubicin Hydrochloride Simoctocog Alfa Gskvx000000017033 Suxamethonium Chloride More therapies…

    Learn about Your Condition

    Erythema Familial hypertriglyceridaemia Epiphysiolysis Deafness Coronary artery dissection Burkitt's lymphoma Haemodynamic instability Ventricular fibrillation Arginase deficiency Interstitial lung disease Arrhythmia supraventricular Lymphatic malformation Myeloid leukaemia Autoimmune hepatitis Petit mal epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Austria Belgium Bulgaria Croatia Czechia France +8

  • A study of ketamine hydrochloride as an additional treatment for patients starting standard antidepressants for major depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Sweden

  • A study to evaluate the safety of REGN7041 in adults with active noninfectious uveitis affecting the back of the eye.

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Uveitis
    France

  • A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Spain

  • Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • ACARBOSE
    • Orlistat
    Sweden
Previous Page
1 … 917 918 919 920 921 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!